.
MergerLinks Header Logo

Announced

Completed

Triton completed the acquisition of Clinigen for $1.8bn.

Financials

Edit Data
Transaction Value£1,207m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium41%
One Off Charge-

Tags

Edit

Single Bidder

Cross Border

Privatisation

Acquisition

Public

Majority

Friendly

United Kingdom

medical products

specialty pharmaceuticals

Pharmaceuticals

related services

pharmaceuticals

Private Equity

Completed

Synopsis

Edit

Triton, an investment firm, completed the acquisition of Clinigen, a global pharmaceutical and health-services company, for $1.8bn. StepStone is participating in the acquisition as a passive co-investor. "The Clinigen Board believes this offer represents an exceptional opportunity for Clinigen shareholders to realise value for their investment in cash at a very attractive valuation. We are therefore unanimously recommending it to our shareholders," Elmar Schnee, Clinigen Chairman. On January 11, 2022, Triton’s Clinigen bid wins support from proxy advisory firms. On January 17, 2022; Triton offers to acquire Clinigen for $1.8bn.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US